Estragole Ameliorates CFA Induced Rheumatoid Arthritis Symptoms in Wistar Rats by Inhibiting JAK-2/STAT-3 Pathway
Language English Country Czech Republic Media print
Document type Journal Article
PubMed
38466007
PubMed Central
PMC11019617
DOI
10.33549/physiolres.935204
PII: 935204
Knihovny.cz E-resources
- MeSH
- Allylbenzene Derivatives * MeSH
- Anisoles * MeSH
- Antioxidants pharmacology therapeutic use MeSH
- Arthritis, Experimental * chemically induced drug therapy MeSH
- Cytokines metabolism MeSH
- Rats MeSH
- Rats, Wistar MeSH
- Arthritis, Rheumatoid * chemically induced drug therapy MeSH
- Animals MeSH
- Check Tag
- Rats MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Names of Substances
- Allylbenzene Derivatives * MeSH
- Anisoles * MeSH
- Antioxidants MeSH
- Cytokines MeSH
- estragole MeSH Browser
The present study was conducted to scrutinize the pharmacological effect of Estragole (ESG) against CFA-induced arthritis in rats. The rats underwent induction of arthritis using the administration of CFA and after that, the rats were randomly divided into five different groups, where three groups correspond to diverse dosages of ESG, and the other two were control and CFA-arthritic control. Results of the study suggested that ESG in a dose-dependent manner, improves body weight and arthritis score of rats as evidenced by reduction of hind-paw volume. ESG also improved the antioxidant status of rats by reducing MDA levels and enhancing the concentration of endogenous antioxidants SOD and GPx. The level of pro-inflammatory cytokines was also found to be reduced in the case of ESG treated group as compared to CFA-group. In a western blot analysis, ESH showed downregulation of p-JAK-2/STAT-3. The study provided concrete evidence for the protective effect of ESG against rheumatoid arthritis in rats.
See more in PubMed
Cai Y, Zhang J, Liang J, Xiao M, Zhang G, Jing Z, Lv L, et al. The Burden of Rheumatoid Arthritis: Findings from the 2019 Global Burden of Diseases Study and Forecasts for 2030 by Bayesian Age-Period-Cohort Analysis. J Clin Med. 2023;12:1291. doi: 10.3390/jcm12041291. PubMed DOI PMC
Rutherford A, Nikiphorou E, Galloway J. Rheumatoid arthritis. In: MIEDANY YE, editor. Comorbidity in Rheumatic Diseases. Springer; 2017. pp. 53–79. DOI
Wu D, Wong P, Guo C, Tam LS, Gu J. Pattern and trend of five major musculoskeletal disorders in China from 1990 to 2017: findings from the Global Burden of Disease Study 2017. BMC Med. 2021;19:34. doi: 10.1186/s12916-021-01905-w. PubMed DOI PMC
Aletaha D, Smolen JS. Diagnosis and Management of Rheumatoid Arthritis: A Review. JAMA. 2018;320:1360–1372. doi: 10.1001/jama.2018.13103. PubMed DOI
Alves EB, Júnior, de Oliveira Formiga R, de Lima Serafim CA, Cristina Araruna ME, de Souza Pessoa ML, Carvalho Vasconcelos R, de Carvalho TG, et al. Estragole prevents gastric ulcers via cytoprotective, antioxidant and immunoregulatory mechanisms in animal models. Biomed Pharmacother. 2020;130:110578. doi: 10.1016/j.biopha.2020.110578. PubMed DOI
Santos BCS, Pires AS, Yamamoto CH, Couri MRC, Taranto AG, Alves MS, Dos Santos de Matos Araújo AL, de Sousa OV. Methyl chavicol and its synthetic analogue as possible antioxidant and antilipase agents based on the in vitro and in silico assays. Oxid Med Cell Longev. 2018;2018:2189348. doi: 10.1155/2018/2189348. PubMed DOI PMC
Silva-Alves KS, Ferreira-da-Silva FW, Peixoto-Neves D, Viana-Cardoso KV, Moreira-Júnior L, Oquendo MB, Oliveira-Abreu K, et al. Estragole blocks neuronal excitability by direct inhibition of Na+ channels. Braz J Med Biol. 2013;46:1056–1063. doi: 10.1590/1414-431X20133191. PubMed DOI PMC
De Souza Silva-Comar FM, Wiirzler LAM, Silva-Filho SE, Kummer R, Pedroso RB, Spironello RA, Silva EL, et al. Effect of estragole on leukocyte behavior and phagocytic activity of macrophages. Evid Based Complement Alternat Med. 2014;2014:784689. doi: 10.1155/2014/784689. PubMed DOI PMC
Ponte EL, Sousa PL, Rocha MVAP, Soares PMG, Coelho-de-Souza AN, Leal-Cardoso JH, Assreuy AMS. Comparative study of the anti-edematogenic effects of anethole and estragole. Pharmacol Rep. 2012;64:984–990. doi: 10.1016/S1734-1140(12)70895-2. PubMed DOI
Zhao X, Wang Y, Wang R, Shen J, Wang J, Li L. Lariciresinol protects rats from complete Freund’s adjuvant-induced arthritis in rats via modulation of transforming growth factor-β and nuclear factor kappa B pathway: An in vivo and in silico study. Chem Biol Drug Des. 2023;102:168–176. doi: 10.1111/cbdd.14268. PubMed DOI
Firestein GS, McInnes IB. Immunopathogenesis of Rheumatoid Arthritis. Immunity. 2017;46:183–196. doi: 10.1016/j.immuni.2017.02.006. PubMed DOI PMC
Kaur A, Nain P, Nain J. Herbal plants used in the treatment of rheumatoid arthritis: A review. Int J Pharm Pharm Sci. 2012;4(Suppl 4):44–57.
Lin B, Zhao Y, Han P, Yue W, Ma X-Q, Rahman K, Zheng C-J, et al. Anti-arthritic activity of Xanthium strumarium L. Extract on complete Freund’s adjuvant induced arthritis in rats. J Ethnopharmacol. 2014;155:248–255. doi: 10.1016/j.jep.2014.05.023. PubMed DOI
Weijers JM, Müskens WD, Van Riel PLCM. Effect of significant weight loss on disease activity: Reason to implement this non-pharmaceutical intervention in daily clinical practice. RMD Open. 2021;7:e001498. doi: 10.1136/rmdopen-2020-001498. PubMed DOI PMC
Sweeney SE, Firestein GS. Rheumatoid arthritis: Regulation of synovial inflammation. Int J Biochem Cell Biol. 2004;36:372–378. doi: 10.1016/S1357-2725(03)00259-0. PubMed DOI
Choy EHS, Panayi GS. Cytokine Pathways and Joint Inflammation in Rheumatoid Arthritis. N Engl J Med. 2001;344:907–916. doi: 10.1056/NEJM200103223441207. PubMed DOI
Luo JG, Zhao XL, Xu W-C, Zhao X-J, Wang J-N, Lin X-W, Sun T, Fu Z-J. Activation of spinal NF-κB/p65 contributes to peripheral inflammation and hyperalgesia in rat adjuvant-induced arthritis. Arthritis Rheumatol. 2014;66:896–906. doi: 10.1002/art.38328. PubMed DOI
Thompson C, Davies R, Choy E. Anti cytokine therapy in chronic inflammatory arthritis. Cytokine. 2016;86:92–99. doi: 10.1016/j.cyto.2016.07.015. PubMed DOI
Mittler R. Oxidative stress, antioxidants and stress tolerance. Trends Plant Sci. 2002;7:405–410. doi: 10.1016/S1360-1385(02)02312-9. PubMed DOI
Blokhina O, Virolainen E, Fagerstedt KV. Antioxidants, oxidative damage and oxygen deprivation stress: A review. Ann Bot. 2003;91:179–194. doi: 10.1093/aob/mcf118. PubMed DOI PMC
Ahmad A, Ali T, Rehman SU, Kim MO. Phytomedicine-based potent antioxidant, fisetin protects CNS-insult LPS-induced oxidative stress-mediated neurodegeneration and memory impairment. J Clin Med. 2019;8:850. doi: 10.3390/jcm8060850. PubMed DOI PMC
Hepel M, Andreescu S. ACS Symposium Series. Vol. 1200. American Chemical Society; 2015. Oxidative Stress and Human Health; Oxidative Stress: Diagnostics, Prevention, and Therapy Volume 2; pp. 1–33. DOI
Migita K, Izumi Y, Torigoshi T, Satomura K, Izumi M, Nishino Y, Jiuchi Y, et al. Inhibition of Janus kinase/signal transducer and activator of transcription (JAK/STAT) signalling pathway in rheumatoid synovial fibroblasts using small molecule compounds. Clin Exp Immunol. 2013;174:356–363. doi: 10.1111/cei.12190. PubMed DOI PMC
Malemud CJ. Intracellular Signaling Pathways in Rheumatoid Arthritis. J Clin Cell Immunol. 2013;4:160. doi: 10.4172/2155-9899.1000160. PubMed DOI PMC
Roskoski R. Janus kinase (JAK) inhibitors in the treatment of inflammatory and neoplastic diseases. Pharmacol Res. 2016;111:784–803. doi: 10.1016/j.phrs.2016.07.038. PubMed DOI
Di Benedetto P, Ruscitti P, Berardicurti O, Panzera N, Grazia N, Di Vito Nolfi M, Di Francesco B, et al. Blocking Jak/STAT signalling using tofacitinib inhibits angiogenesis in experimental arthritis. Arthritis Res Ther. 2021;23:213. doi: 10.1186/s13075-021-02587-8. PubMed DOI PMC
Simon LS, Taylor PC, Choy EH, Sebba A, Quebe A, Knopp KL, Porreca F. The Jak/STAT pathway: A focus on pain in rheumatoid arthritis. Semin Arthritis Rheum. 2021;51:278–284. doi: 10.1016/j.semarthrit.2020.10.008. PubMed DOI
Meng XY, Zhang HX, Mezei M, Cui M. Molecular Docking: A Powerful Approach for Structure-Based Drug Discovery. Curr Comput Aided Drug Des. 2012;7:146–157. doi: 10.2174/157340911795677602. PubMed DOI PMC
Sahu S, Ghosh SK, Gahtori P, Pratap Singh U, Bhattacharyya DR, Bhat HR. In silico ADMET study, docking, synthesis and antimalarial evaluation of thiazole-1,3,5-triazine derivatives as Pf-DHFR inhibitor. Pharmacol Rep. 2019;71:762–767. doi: 10.1016/j.pharep.2019.04.006. PubMed DOI
Singh UP, Singh RK. Molecular docking analysis of novel Non-Nucleoside Reverse Transcriptase Inhibitors in development: implication for rational drug design. Retrovirology. 2011;8:P82. doi: 10.1186/1742-4690-8-S2-P82. DOI
Singh UP, Bhat HR, Gahtori P, Singh RK. Hybrid phenylthiazole and 1,3,5-triazine target cytosolic leucyl-tRNA synthetase for antifungal action as revealed by molecular docking studies. In Silico Pharmacol. 2013;1:3. doi: 10.1186/2193-9616-1-3. PubMed DOI PMC
Singh UP, Pathak M, Dubey V, Bhat HR, Gahtori P, Singh RK. Design, Synthesis, Antibacterial Activity, and Molecular Docking Studies of Novel Hybrid 1,3-Thiazine-1,3,5-Triazine Derivatives as Potential Bacterial Translation Inhibitor. Chem Biol Drug Des. 2012;80:572–583. doi: 10.1111/j.1747-0285.2012.01430.x. PubMed DOI
Liu Y, Grimm M, Dai W-T, Hou M-C, Xiao Z-X, Cao Y. CB-Dock: a web server for cavity detection-guided protein-ligand blind docking. Acta Pharmacol Sin. 2020;41:138–144. doi: 10.1038/s41401-019-0228-6. PubMed DOI PMC
Liu Y, Yang X, Gan J, Chen S, Xiao ZX, Cao Y. CB-Dock2: improved protein-ligand blind docking by integrating cavity detection, docking and homologous template fitting. Nucleic Acids Res. 2022;50:W159–W164. doi: 10.1093/nar/gkac394. PubMed DOI PMC